Cargando…
A new perspective in sepsis treatment: could RGD-dependent integrins be novel targets?
Sepsis is a life-threatening condition caused by the response of the body to an infection, and has recently been regarded as a global health priority because of the lack of effective treatments available. Vascular endothelial cells have a crucial role in sepsis and are believed to be a major target...
Autores principales: | Nader, Danielle, Curley, Gerard F., Kerrigan, Steven W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537604/ https://www.ncbi.nlm.nih.gov/pubmed/33035665 http://dx.doi.org/10.1016/j.drudis.2020.09.038 |
Ejemplares similares
-
SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19
por: Nader, Danielle, et al.
Publicado: (2021) -
Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022) -
RGD-Binding Integrins in Head and Neck Cancers
por: Ahmedah, Hanadi Talal, et al.
Publicado: (2017) -
Human endothelial cell-derived exosomal microRNA-99a/b drives a sustained inflammatory response during sepsis by inhibiting mTOR expression
por: Fitzpatrick, Glenn, et al.
Publicado: (2022) -
Beyond RGD: virus interactions with integrins
por: Hussein, Hosni A. M., et al.
Publicado: (2015)